These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27545880)

  • 1. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.
    Katsumura KR; Ong IM; DeVilbiss AW; Sanalkumar R; Bresnick EH
    Cell Rep; 2016 Aug; 16(9):2428-41. PubMed ID: 27545880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of crosstalk between oncogenic Ras and the master regulator of hematopoiesis GATA-2.
    Katsumura KR; Yang C; Boyer ME; Li L; Bresnick EH
    EMBO Rep; 2014 Sep; 15(9):938-47. PubMed ID: 25056917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
    Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
    Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells.
    Chen JY; Lai YS; Tsai HJ; Kuo CC; Yen BL; Yeh SP; Sun HS; Hung WC
    Sci Rep; 2016 Aug; 6():32428. PubMed ID: 27577048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
    Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
    Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
    Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
    Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two effects of GATA2 enhancer repositioning by 3q chromosomal rearrangements.
    Suzuki M; Katayama S; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):159-169. PubMed ID: 31820561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CXCL2 and CCL2 by pressure force requires IL-1β-MyD88 axis in osteoblasts.
    Maeda A; Bandow K; Kusuyama J; Kakimoto K; Ohnishi T; Miyawaki S; Matsuguchi T
    Bone; 2015 May; 74():76-82. PubMed ID: 25603464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
    Luesink M; Hollink IH; van der Velden VH; Knops RH; Boezeman JB; de Haas V; Trka J; Baruchel A; Reinhardt D; van der Reijden BA; van den Heuvel-Eibrink MM; Zwaan CM; Jansen JH
    Blood; 2012 Sep; 120(10):2064-75. PubMed ID: 22786876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.
    Pang Y; Zhao Y; Wang Y; Wang X; Wang R; Liu N; Li P; Ji M; Ye J; Sun T; Li J; Ma D; Lu F; Ji C
    J Exp Clin Cancer Res; 2020 Aug; 39(1):158. PubMed ID: 32795319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1.
    Stassen M; Klein M; Becker M; Bopp T; Neudörfl C; Richter C; Heib V; Klein-Hessling S; Serfling E; Schild H; Schmitt E
    Mol Immunol; 2007 Feb; 44(5):926-33. PubMed ID: 16650898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia.
    Hao X; Gu M; Sun J; Cong L
    J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL2 benefits acute myeloid leukemia cells in hypoxia.
    Li L; Zhao L; Man J; Liu B
    Int J Lab Hematol; 2021 Oct; 43(5):1085-1092. PubMed ID: 33793061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells.
    Menendez-Gonzalez JB; Sinnadurai S; Gibbs A; Thomas LA; Konstantinou M; Garcia-Valverde A; Boyer M; Wang Z; Boyd AS; Blair A; Morgan RG; Rodrigues NP
    Sci Rep; 2019 Aug; 9(1):12212. PubMed ID: 31434974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
    Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.
    Zhang H; Ye YL; Li MX; Ye SB; Huang WR; Cai TT; He J; Peng JY; Duan TH; Cui J; Zhang XS; Zhou FJ; Wang RF; Li J
    Oncogene; 2017 Apr; 36(15):2095-2104. PubMed ID: 27721403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.
    Fang F; Xu J; Kang Y; Ren H; Muyey DM; Chen X; Tan Y; Xu Z; Wang H
    Int J Lab Hematol; 2021 Dec; 43(6):1491-1500. PubMed ID: 34374210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.